Posted on 11/8/18
Trevena Reports Third Quarter 2018 Financial Results and Announces Workforce Restructuring
CHESTERBROOK, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of new and innovative treatment . . .
Posted on 11/8/18
Zynerba Pharmaceuticals Reports Third Quarter 2018 Financial Results and Operational Highlights
DEVON, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, . . .
Posted on 11/8/18
Celgene: Money Will Flow Back
Summary Celgene dipped to multi-year lows of $70. The major culprit was biotech sector weakness causing money to flow away. The net payout yield has surged . . .
Posted on 11/8/18
Here's Why PTC Therapeutics Dropped 18% in October
What happenedShares of PTC Therapeutics (NASDAQ:PTCT) fell exactly 18% last month, according to data provided by S&P Global Market Intelligence. The development-stage biopharma stock took a . . .
Posted on 11/8/18
Celldex Provides Corporate Update and Reports Q3 2018 Results
HAMPTON, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the third quarter ended September 30, 2018. . . .
Posted on 11/8/18
Immunomedics Expands Clinical Collaboration With Astrazeneca
MORRIS PLAINS, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ: IMMU) , a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced . . .
Posted on 11/7/18
Bellerophon Provides Business Update and Reports Q3 2018 Financial Results
WARREN, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company, today provided a business update and reported financial results . . .
Posted on 11/7/18
GNC and Hayao Reach Agreement for Funding of $300 Million Strategic Investment
PITTSBURGH, Nov. 07, 2018 (GLOBE NEWSWIRE) -- GNC Holdings, Inc. (NYSE: GNC) announced today that it has reached an agreement with Harbin Pharmaceutical Group Co., Ltd. . . .
Posted on 11/7/18
Amneal Announces Solid Third Quarter 2018 Financial Results
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced its results today for the quarter ended September 30, 2018. "The third quarter was defined by solid financial performance and strategic . . .
Posted on 11/7/18
What Can Doctors Learn From Creative Writing?
YouTubing doctor David Hindin dropped a new episode of his online series on healthcare innovation — aptly titled
Posted on 11/6/18
Spark Therapeutics Reports Q3 2018 Financial Results and Recent Business Progress
PHILADELPHIA, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, . . .
Posted on 11/6/18
Delta Dental Community Care Foundation awards $75,000 grant to Mission of Mercy
The Delta Dental Community Care Foundation announced today that it awarded Mission of Mercy a $75,000 grant to support its mobile dental clinic operating in Maryland . . .
Posted on 11/6/18
Tabula Rasa HealthCare Announces Third Quarter 2018 Operating Results
MOORESTOWN, N.J., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced its financial . . .
Posted on 11/6/18
Neuronetics Reports Third Quarter 2018 Financial and Operating Results
MALVERN, Pa., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve . . .
Posted on 11/6/18
Madrigal Pharmaceuticals Reports 2018 Third Quarter Financial Results
CONSHOHOCKEN, Pa., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) today announced its third quarter 2018 financial results and described upcoming clinical events:“Madrigal made . . .
Posted on 11/5/18
Advaxis Provides Update on Clinical Pipeline
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced that it will be continuing . . .
Posted on 11/2/18
Evaluating Pfizer's Growth Plans And Valuation
Summary PFE had a mild downside reaction to a minimal miss on Q3 sales. But the stock remains in an uptrend, having increased its price:sales ratio . . .
Posted on 11/2/18
4 Reasons To Buy Teva
SummaryTeva Pharmaceuticals just reported strong earnings.The company's restructuring is progressing according to plan.Bleeding on Copaxone looks like it has slowed down to a trickle.EPS and EBITDA . . .
Posted on 11/2/18
Why Teva Pharmaceutical Industries Ltd. Stock Crushed It Today
What happenedShares of Israeli generic-drug giant Teva Pharmaceutical Industries Limited(NYSE:TEVA) ended today's trading session up by a healthy 15% on above-average volume. The spark? Teva's stock . . .
Posted on 11/2/18
Onconova Therapeutics to Provide Corporate Update
NEWTOWN, Pa., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to . . .
Posted on 11/1/18
Eagle Pharmaceuticals Reports Third Quarter 2018 Results
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) today announced its financial results for the three and nine months ended September 30, 2018. Highlights of and . . .
Posted on 11/1/18
Teleflex Reports Third Quarter 2018 Results
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 30, 2018.Third quarter 2018 net revenues were $609.7 . . .
Posted on 11/1/18
Zoetis Announces Third Quarter 2018 Results
PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the third quarter of 2018 and updated its guidance for full year 2018. The company . . .
Posted on 11/1/18
Edge Therapeutics Reports Third Quarter 2018 Financial Results
BERKELEY HEIGHTS, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE) today announced financial results for the quarter ended September 30, 2018.Third Quarter . . .
Posted on 11/1/18
Children's Hospital of Philadelphia Opens Manufacturing Facility
For over a century after the Civil War, Philadelphia laid claim to being the "Workshop of the World," producing trains, tools, textiles and a multitude of . . .

